Solana Co. Files 8-K: Regulation FD & Financials

Ticker: HSDT · Form: 8-K · Filed: Nov 3, 2025 · CIK: 1610853

Solana Co 8-K Filing Summary
FieldDetail
CompanySolana Co (HSDT)
Form Type8-K
Filed DateNov 3, 2025
Risk Levellow
Pages2
Reading Time3 min
Key Dollar Amounts$0.001
Sentimentneutral

Sentiment: neutral

Topics: disclosure, financials, regulation-fd

TL;DR

Solana Co. dropped an 8-K on Nov 3rd covering Reg FD and financials. Check it out.

AI Summary

On November 3, 2025, Solana Co. filed an 8-K report. The filing primarily concerns Regulation FD Disclosure and Financial Statements and Exhibits. The company, formerly Helius Medical Technologies, Inc., is incorporated in Delaware and operates in the Electromedical & Electrotherapeutic Apparatus industry.

Why It Matters

This 8-K filing provides important disclosures regarding Solana Co.'s regulatory compliance and financial reporting, which are crucial for investors to assess the company's current status.

Risk Assessment

Risk Level: low — This filing is a routine disclosure of financial statements and regulatory information, not indicating any immediate operational or financial distress.

Key Numbers

  • 0001610853 — Central Index Key (Unique identifier for the filer)
  • 001-38445 — Commission File Number (SEC file number for the company)
  • 364787690 — IRS Employer Identification No. (Company's tax identification number)

Key Players & Entities

  • Solana Co. (company) — Registrant
  • November 3, 2025 (date) — Date of Report
  • Helius Medical Technologies, Inc. (company) — Former Company Name
  • Delaware (jurisdiction) — State of Incorporation
  • 3845 (industry_code) — Standard Industrial Classification

FAQ

What specific financial statements are included in this 8-K filing?

The filing indicates that 'Financial Statements and Exhibits' are included, but the specific details of these statements are not provided in the excerpt.

What is the primary purpose of this 8-K filing for Solana Co.?

The primary purposes are Regulation FD Disclosure and the filing of Financial Statements and Exhibits.

When was Solana Co. formerly known as Helius Medical Technologies, Inc.?

The filing shows multiple name change dates for Helius Medical Technologies, Inc., including 20180525, 20180517, and 20140613.

What is Solana Co.'s Standard Industrial Classification code?

Solana Co.'s Standard Industrial Classification code is 3845, which corresponds to Electromedical & Electrotherapeutic Apparatus.

Where is Solana Co. headquartered?

Solana Co.'s principal executive address is 642 Newtown Yardley Road, Suite 100, Newtown, PA 18940.

Filing Stats: 743 words · 3 min read · ~2 pages · Grade level 10.9 · Accepted 2025-11-03 09:25:14

Key Financial Figures

  • $0.001 — hich registered Class A Common Stock, $0.001 par value HSDT The Nasdaq Stock Mar

Filing Documents

01 Regulation FD Disclosure

Item 7.01 Regulation FD Disclosure. On November 3, 2025, Solana Company (formerly known as Helius Medical Technologies, Inc.) (the "Company") posted a corporate presentation (the "Investor Update") to its website at www.solanacompany.co/about, which the Company may use from time to time in communications or conferences. A copy of the Investor Update is attached hereto as Exhibit 99.1 and incorporated herein by reference. On November 3, 2025, the Company also issued a press release. A copy of the press release is attached hereto as Exhibit 99.2 and incorporated herein by reference. Information contained on or accessible through any website reference in this Current Report, Exhibit 99.1 or Exhibit 99.2 attached hereto is not part of, or incorporated by reference in, this Current Report, and the inclusion of such website addresses in this Current Report, including by incorporation by reference of Exhibit 99.1 and Exhibit 99.2, is as inactive textual references only. The information in this Current Report, including in Exhibit 99.1 and Exhibit 99.2 hereto, is furnished pursuant to Item 7.01 and shall not be deemed "filed" for purposes of Section 18 of the Securities Exchange Act of 1934, as amended (the "Exchange Act"), or otherwise subject to the liabilities of that Section, nor shall it be deemed incorporated by reference in any filing under the Securities Act of 1933, as amended, or the Exchange Act, except as expressly set forth by specific reference in such filing. The Company's submission of this Current Report shall not be deemed an admission as to the materiality of any information required to be disclosed solely to satisfy the requirements of Regulation FD. This Current Report, Exhibit 99.1 and Exhibit 99.2 contain forward-looking statements within the meaning of the federal securities laws. These forward-looking statements are based on current expectations and are not guarantees of future performance. Further, the forward-looking statements are subject to

Financial Statements and Exhibits

Financial Statements and Exhibits. (d) Exhibits Exhibit No. Description 99.1 Corporate Presentation, dated November 2025 . 99.2 Press Release, dated November 3, 2025 . 104 Cover Page Interactive Data File (embedded within Inline XBRL document). 2 SIGNATURE Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized. SOLANA COMPANY. Dated: November 3, 2025 By: /s/ Jeffrey S. Mathiesen Jeffrey S. Mathiesen Chief Financial Officer, Treasurer and Secretary 3

View Full Filing

View this 8-K filing on SEC EDGAR

View on ReadTheFiling | About | Contact | Privacy | Terms

Data from SEC EDGAR. Not affiliated with the SEC. Not investment advice. © 2026 OpenDataHQ.